1. Home
  2. MOLN vs DSP Comparison

MOLN vs DSP Comparison

Compare MOLN & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.04

Market Cap

157.8M

Sector

N/A

ML Signal

HOLD

Logo Viant Technology Inc.

DSP

Viant Technology Inc.

HOLD

Current Price

$12.00

Market Cap

184.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOLN
DSP
Founded
2004
1999
Country
Switzerland
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
157.8M
184.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
MOLN
DSP
Price
$4.04
$12.00
Analyst Decision
Hold
Strong Buy
Analyst Count
1
8
Target Price
$3.75
$18.50
AVG Volume (30 Days)
3.4K
261.6K
Earning Date
10-30-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.49
EPS
N/A
0.10
Revenue
N/A
$324,131,000.00
Revenue This Year
N/A
$17.79
Revenue Next Year
$1,000.00
$17.72
P/E Ratio
N/A
$120.95
Revenue Growth
N/A
22.97
52 Week Low
$3.36
$8.11
52 Week High
$5.91
$26.33

Technical Indicators

Market Signals
Indicator
MOLN
DSP
Relative Strength Index (RSI) 52.36 64.95
Support Level $3.98 $11.10
Resistance Level $4.35 $12.26
Average True Range (ATR) 0.19 0.55
MACD -0.02 -0.01
Stochastic Oscillator 52.17 77.17

Price Performance

Historical Comparison
MOLN
DSP

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.

Share on Social Networks: